{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Clavulanate+potassium&page=2", "query": { "intervention": "Clavulanate potassium", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 61, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Clavulanate+potassium&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Clavulanate+potassium&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T05:29:06.837Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07732699", "title": "Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "ACUTE SINUSITIS", "Sinusitis" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxi Clavulanate", "type": "DRUG" }, { "name": "Amoxicillin Placebo", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nader Shaikh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 1100, "start_date": "2026-10-01", "completion_date": "2032-03-17", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 5, "location_summary": "Denver, Colorado • Durham, North Carolina • Cincinnati, Ohio + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07732699" }, { "nct_id": "NCT05584683", "title": "A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pediatric", "Bacterial Infections" ], "interventions": [ { "name": "Amoxicillin potassium clavulanate", "type": "DRUG" }, { "name": "Amoxicillin potassium clavulanate (Augmentin ES-600)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kaizen Bioscience Co.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "3 Months to 24 Months" }, "enrollment_count": 39, "start_date": "2023-08-09", "completion_date": "2024-12-16", "has_results": false, "last_update_posted_date": "2025-02-05", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05584683" }, { "nct_id": "NCT01110408", "title": "A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infections or Pyelonephritis" ], "interventions": [ { "name": "Doripenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Cefepime placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 41, "start_date": "2010-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 11, "location_summary": "Little Rock, Arkansas • Oakland, California • Orange, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110408" }, { "nct_id": "NCT01511107", "title": "Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Otitis Media" ], "interventions": [ { "name": "Amoxicillin-Clavulanate, 10 days", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate, 5 days", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alejandro Hoberman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "6 Months to 23 Months" }, "enrollment_count": 520, "start_date": "2012-01", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-10-06", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 2, "location_summary": "Bardstown, Kentucky • Pittsburgh, Pennsylvania", "locations": [ { "city": "Bardstown", "state": "Kentucky" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01511107" }, { "nct_id": "NCT02891915", "title": "Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Cefdinir", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "6 Months to 71 Months" }, "enrollment_count": 385, "start_date": "2016-12-02", "completion_date": "2019-12-16", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Louisville, Kentucky + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02891915" }, { "nct_id": "NCT02554383", "title": "Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sinusitis", "Respiratory Tract Infections" ], "interventions": [ { "name": "Amoxicillin-clavulanate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nader Shaikh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 515, "start_date": "2016-02", "completion_date": "2023-03-09", "has_results": true, "last_update_posted_date": "2023-06-29", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 6, "location_summary": "Bardstown, Kentucky • Gresham, Oregon • Philadelphia, Pennsylvania + 3 more", "locations": [ { "city": "Bardstown", "state": "Kentucky" }, { "city": "Gresham", "state": "Oregon" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02554383" }, { "nct_id": "NCT01110421", "title": "A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia, Bacterial", "Community-Acquired Infections", "Nosocomial Infection", "Pneumonia, Ventilator-Associated" ], "interventions": [ { "name": "Cefepime placebo", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Doripenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 7, "start_date": "2010-12", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 4, "location_summary": "Little Rock, Arkansas • Cleveland, Ohio • Toledo, Ohio + 1 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110421" }, { "nct_id": "NCT03755765", "title": "Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Antibiotic-associated Diarrhea" ], "interventions": [ { "name": "Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet", "type": "DRUG" }, { "name": "BB-12", "type": "BIOLOGICAL" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 66, "start_date": "2019-07-23", "completion_date": "2020-01-08", "has_results": true, "last_update_posted_date": "2023-02-17", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03755765" }, { "nct_id": "NCT05584657", "title": "Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infections", "Cystitis" ], "interventions": [ { "name": "Sulopenem etzadroxil/probenecid", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 2229, "start_date": "2022-10-18", "completion_date": "2023-11-21", "has_results": true, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 167, "location_summary": "Cullman, Alabama • Saraland, Alabama • Sheffield, Alabama + 126 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Saraland", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05584657" }, { "nct_id": "NCT07492134", "title": "APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Uncomplicated Diverticulitis" ], "interventions": [ { "name": "Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Cefuroxime", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 100, "start_date": "2026-07-07", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-30T05:29:06.837Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07492134" } ] }